drugset / Trial / NCT05740969

Gene and Protein Expression Profiles After Treatment of Actinic Keratoses

NCT05740969

Phase 2 Unknown 48 enrolled Ismail Gögenur
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of this study is to investigate the effect of 5-fluorouracil, imiquimod, and melatonin for actinic keratosis on immunological gene, and protein expressions profiles. Secondarily, the aim is to assess the effect of the treatment on the histopathology of actinic keratoses.

Timeline

Start
2023-02-01
Primary completion
2024-02-01
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imiquimod Other / unclassified 5 % Topical
Subject Melatonin Small molecule 2.5 % Topical
Comparator fluorouracil Small molecule 4 % Topical

Indications